Integrated Biopharma Inc (INBP): Cash & Equivalents
$4.47M
As of 2026-06-30
+50.3%
3-year compound annual growth
+84.3%
5-year compound annual growth
+27.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $4.47M | +23.7% | 2026-09-25, Balance as of period end |
| 2025-06-30 | $3.62M | +115.6% | 2026-09-25, Balance as of period end |
| 2024-06-30 | $1.68M | +27.4% | 2025-09-23, Balance as of period end |
| 2023-06-30 | $1.32M | +297.6% | 2024-09-20, Balance as of period end |
| 2022-06-30 | $331.0K | +57.6% | 2023-09-15, Balance as of period end |
| 2021-06-30 | $210.0K | -47.8% | 2022-09-13, Balance as of period end |
| 2020-06-30 | $402.0K | -15.4% | 2021-09-02, Balance as of period end |
| 2019-06-30 | $475.0K | +108.3% | 2020-09-23, Balance as of period end |
| 2018-06-30 | $228.0K | +72.7% | 2019-08-29, Balance as of period end |
| 2017-06-30 | $132.0K | -66.6% | 2018-09-12, Balance as of period end |
| 2016-06-30 | $395.0K | +456.3% | 2017-09-01, Balance as of period end |
| 2015-06-30 | $71.0K | -84.3% | 2016-09-02, Balance as of period end |
| 2014-06-30 | $451.0K | +720.0% | 2015-09-04, Balance as of period end |
| 2013-06-30 | $55.0K | -62.1% | 2014-09-08, Balance as of period end |
| 2012-06-30 | $145.0K | -80.0% | 2013-09-30, Balance as of period end |
| 2011-06-30 | $725.0K | n/a | 2012-10-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $4.47M | +23.7% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $137.53M | +148.7% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $11.44M | -36.3% |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | $602.07M | +99.3% |
| Septerna, Inc. (SEPN) | 2025-12-31 | $120.72M | -49.3% |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | $128.39M | +32.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $6.39M | +8.2% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $37.73M | -18.1% |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | $34.33M | -48.5% |
Compare INBP, XLO, CPIX, WVE side by side · Screen every company in Pharmaceutical Preparations ↗